- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00390507
Modification of Posttetanic Count (PTC) for Monitoring Deep Neuromuscular Block II
September 2, 2010 updated by: Rigshospitalet, Denmark
The purpose of this study is to examine the relationship between post-tetanic count (PTC) and time to first response to Train of four (TOF) stimulation during deep neuromuscular blockade induced by rocuronium.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
45
Phase
- Phase 4
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Copenhagen, Denmark, 2100
- Dep. of Anesthesia, Rigshospitalet
-
Herlev, Denmark, 2730
- Dep. of Anesthesia, Herlev hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- ASA 1-3
- General anaesthesia >1 hour
- Surgery in supine position with possibility of monitoring the neuromuscular blockade at the thumb (n.ulnaris stimulation).
- Written informed content
Exclusion Criteria:
- Neuromuscular disorders, hepatic and renal dysfunction
- Medication expected to interfere with the neuromuscular blocking agent
- Allergy to any medication used during anaesthesia
- Body weight less or exceeding 20% of the ideal body weight
- Pregnancy or breastfeeding
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
|---|
|
Time to first response to TOF stimulation (T1)
|
Secondary Outcome Measures
Outcome Measure |
|---|
|
Time to T1=25%
|
|
Interval 25-75%
|
|
Time to second response to TOF stimulation (T2)
|
|
Time to first post-tetanic count (PTC)
|
|
Number of post-tetanic count at first response to TOF
|
|
Time to TOF 0.9
|
|
Time to TOF 1.0
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2006
Primary Completion (ACTUAL)
April 1, 2010
Study Registration Dates
First Submitted
October 19, 2006
First Submitted That Met QC Criteria
October 19, 2006
First Posted (ESTIMATE)
October 20, 2006
Study Record Updates
Last Update Posted (ESTIMATE)
September 6, 2010
Last Update Submitted That Met QC Criteria
September 2, 2010
Last Verified
September 1, 2010
More Information
Terms related to this study
Other Study ID Numbers
- PTC-II
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.